Literature DB >> 3394549

Vascular permeability and cell kinetics of ethylnitrosourea (ENU)-induced rat brain tumours.

T Inoue1, T Tashima, S Nishio, I Takeshita, T Iwaki, M Fukui.   

Abstract

Vascular permeability and proliferative activity of ethylnitrosourea (ENU)-induced rat brain tumours were studied by intravenous injection of Evans blue dye (EB) and by bromodeoxyuridine (BrdU) uptake examinations. Tumours induced by ENU showed various histologial types, and they were oligodendrogliomas, mixed oligo-astrocytomas, mixed oligo-ependymomas, astrocytomas, anaplastic astrocytomas, polymorphic gliomas, and ependymomas. The labelling indexes (LIs: the ratio of BrdU-labelled cells to total cells) of tumour and vascular component cells in the tumour were high in anaplastic astrocytomas, polymorphic gliomas and ependymomas, but low in oligodendrogliomas. EB stained anaplastic astrocytomas, polymorphic gliomas and ependymomas deeply, but did not penetrate oligodendrogliomas. In mixed gliomas, EB staining and the LIs of tumour cells were not uniform. After intracarotid infusion of hyperosmolar mannitol into tumour-bearing rats, tumour staining with EB and the LIs of tumour cells were not increased, whereas the penetration of EB into the normal brain was drastically increased. Therefore it is not likely that the delivery of chemotherapeutic drugs to the tumour could be increased by intracarotid infusion of hyperosmolar mannitol. Our data suggest that the vascular permeability of tumour vessels is highly correlated with the high proliferative activity of tumour and its vascular cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3394549     DOI: 10.1007/bf01400531

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  28 in total

1.  Proliferative potential of vascular components in human glioblastoma multiforme.

Authors:  T Nagashima; T Hoshino; K G Cho
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

2.  Cell turnover of capillaries.

Authors:  R L Engerman; D Pfaffenbach; M D Davis
Journal:  Lab Invest       Date:  1967-12       Impact factor: 5.662

3.  Teratogenic and carcinogenic effects in the offspring after single injection of ethylnitrosourea to pregnant rats.

Authors:  H Druckrey; S Ivanković; R Preussmann
Journal:  Nature       Date:  1966-06-25       Impact factor: 49.962

4.  Hyperosmotic blood-brain barrier disruption in brains of rats with an intracerebrally transplanted RG-C6 tumor.

Authors:  T Inoue; M Fukui; S Nishio; K Kitamura; H Nagara
Journal:  J Neurosurg       Date:  1987-02       Impact factor: 5.115

5.  The development of experimental brain tumours a sequential light and electron microscope study of the subependymal plate. II. Microtumours.

Authors:  G J Pilkington; P L Lantos
Journal:  Acta Neuropathol       Date:  1979-03-15       Impact factor: 17.088

6.  Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier.

Authors:  E A Neuwelt; P A Barnett; D D Bigner; E P Frenkel
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

7.  The effect of graded hypertonic intracarotid infusions on drug delivery to experimental RG-2 gliomas.

Authors:  H Nakagawa; D Groothuis; R G Blasberg
Journal:  Neurology       Date:  1984-12       Impact factor: 9.910

8.  Regional blood flow and capillary permeability in the ethylnitrosourea-induced rat glioma.

Authors:  K Yamada; T Hayakawa; Y Ushio; N Arita; A Kato; H Mogami
Journal:  J Neurosurg       Date:  1981-12       Impact factor: 5.115

9.  Experimental brain tumors by transplacental ENU. Multifactorial study of the latency period.

Authors:  D Schiffer; M T Giordana; A Mauro; G Racagni; F Bruno; S Pezzotta; P Paoletti
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

10.  The fine structure of blood vessels in ethylnitrosourea-induced tumours of the rat nervous system: with special reference to the breakdown of the blood-brain barrier.

Authors:  D J Cox; G J Pilkington; P L Lantos
Journal:  Br J Exp Pathol       Date:  1976-08
View more
  2 in total

Review 1.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1995-12

Review 2.  The application of 5-bromodeoxyuridine in the management of CNS tumors.

Authors:  A Freese; D O'Rourke; K Judy; M J O'Connor
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.